Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Active, not recruiting · NCT05552469 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-09-10 | NCT05552469 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 133 |
| H Lee Moffitt Cancer Center and Research Institute | Tampa | United States | 11 |
| Huntsman Cancer Institute | Salt Lake City | United States | 107 |
| Mayo Clinic Rochester | Rochester | United States | 133 |
| Memorial Sloan Kettering Cancer Ctr | New York | United States | 9 |
| Northwestern University | Chicago | United States | 727 |
| Sidney Kimmel CCC At JH | Baltimore | United States | 2 |
| Stanford Cancer Center | Stanford | United States | 10 |
| Univ of TX MD Anderson Cancer Cntr | Houston | United States | 4 |
| Vanderbilt University Medical Ctr | Nashville | United States | 2 |
| Weill Cornell Medicine NY-Presb | New York | United States | 2 |